참고문헌 (40)

1. Kashem SW, Haniffa M, Kaplan DH. Antigen-presenting cells in the skin. Annual review of immunology. 2017;35:469-499.？ 

   상세보기

2. Mathers AR, Larregina AT. Professional antigen-presenting cells of the skin. Immunologic research. 2006;36:127-136.？ 

   상세보기

3. Ariotti S, Beltman JB, Chodaczek G, Hoekstra ME, Van Beek AE, Gomez ER, Ritsma L, Van RJ, Maree AF, Zal T. Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proceedings of the National Academy of Sciences. 2012;109(48):19739-19744.？ 

4. Schroder JM. Cytokine networks in the skin. Journal of investigative dermatology. 1995;105(1):S20-S24.？ 

   상세보기

5. Hanel KH, Cornelissen C, Luscher B, Baron JM. Cytokines and the skin barrier. International journal of molecular sciences. 2013;14(4):6720-6745.？ 

   상세보기

6. Sebastiani S, Albanesi C, De Pita O, Puddu P, Cavani A, Girolomoni G. The role of chemokines in allergic contact dermatitis. Archives of dermatological research. 2002;293:552-559.？ 

   상세보기

7. Nedoszytko B, Sokolowska WM, Ruckemann DK, Roszkiewicz J, Nowicki R. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis. Advances in Dermatology and Allergology/Postepy Dermatologii i Alergologii. 2014;31(2):84-91.？ 

8. Campo GM, Avenoso A, Campo S, Angela DA, Ferlazzo AM, Calatroni A. TNF-α, IFN-γ, and IL-1β modulate hyaluronan synthase expression in human skin fibroblasts: Synergistic effect by concomital treatment with FeSO 4 plus ascorbate. Molecular and cellular biochemistry. 2006;292:169-178.？ 

9. Skurkovich B, Skurkovich S. Inhibition of IFN-γ as a method of treatment of various autoimmune diseases, including skin diseases. Cytokines as Potential Therapeutic Targets for Inflammatory Skin Diseases. 2006:1-27.？ 

10. Van der ZH, De Ruiter L, Van Den BD, Dik W, Laman J, Prens E. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. British Journal of Dermatology. 2011;164(6):1292-1298.？ 

11. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N. The essential involvement of cross-talk between IFN-γ and TGF-β in the skin wound-healing process. The Journal of Immunology. 2004;172(3):1848-1855.？ 

12. Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, Bruijnzeel KCA, Clark RA. CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22. Journal of Investigative Dermatology. 2013;133(4):973-979.？ 

13. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunological reviews. 2011;242(1):233-246.？ 

    상세보기

14. Evers A, Lu Y, Duller P, Van Der VP, Kraaimaat FW, Van De KP. Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. British Journal of Dermatology. 2005;152(6):1275-1281.？ 

    상세보기

15. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. Journal of allergy and clinical immunology. 1995;96(3):302-319.？ 

    상세보기

16. Moynagh PN. The NF-κB pathway. Journal of cell science. 2005;118(20):4589-4592.？ 

17. Yamamoto Y, Gaynor RB. Role of the NF-kB pathway in the pathogenesis of human disease states. Current molecular medicine. 2001;1(3):287-296.？ 

18. Senftleben U, Karin M. The Ikk/nf-κb pathway. Critical care medicine. 2002;30(1):S18-S26.？ 

19. Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor perspectives in biology. 2009;1(6):a001651.？ 

20. Yamamoto Y, Gaynor RB. IκB kinases: key regulators of the NF-κB pathway. Trends in biochemical sciences. 2004;29(2):72-79.？ 

21. Zhou D, Yu T, Chen G, Brown S, Yu Z, Mattson M, Thompson J. Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivo. International journal of radiation biology. 2001;77(7):763-772.？ 

22. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G. Characterization of a functional NF-κB site in the human interleukin 1β promoter: evidence for a positive autoregulatory loop. Molecular and cellular biology. 1993;13(10):6231-6240.？ 

23. Flodstroma M, Welsh N, Eizirik DL. Cytokines activate the nuclear factor κB (NF-κB) and induce nitric oxide production in human pancreatic islets. FEBS letters. 1996;385(1-2):4-6.？ 

24. Meier Kriesche HU, Li S, Gruessner R, Fung J, Bustami RT, Barr M, Leichtman AB. Immunosuppression: evolution in practice and trends, 1994-2004. American Journal of Transplantation. 2006;6(5):1111-1131.？ 

    상세보기

25. Khurana A, Brennan DC. Current concepts of immunosuppression and side effects. Pathology of solid organ transplantation. 2010:11-30.？ 

26. Kim JY, Lee JY, Lee JW, Lee SK, Park CS, Yang SJ, Lee YH. Evaluation of Atopic Dermatitis Improvement Caused by Low-Level, Low-Frequency Pulsed Electromagnetic Fields. Bioelectromagnetics. 2022;43(4):268-277.？ 

    상세보기

27. Ross CL, Zhou Y, McCall CE, Soker S, Criswell TL. The use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: A review. Bioelectricity. 2019;1(4):247-259.？ 

    상세보기

28. Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Goldring MB, Borea PA, Varani K. Pulsed electromagnetic fields increased the anti-inflammatory effect of A2A and A3 adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. PloS one. 2013;8(5):e65561.？ 

    상세보기

29. Vincenzi F, Ravani A, Pasquini S, Merighi S, Gessi S, Setti S, Cadossi R, Borea PA, Varani K. Pulsed electromagnetic field exposure reduces hypoxia and inflammation damage in neuron-like and microglial cells. Journal of Cellular Physiology. 2017;232(5):1200-1208.？ 

    상세보기

30. Li S, Ni Z, Cong B, Gao W, Xu S, Wang C, Yao Y, Ma C, Ling Y. CCK-8 inhibits LPS-induced IL-1β production in pulmonary interstitial macrophages by modulating PKA, p38, and NF-κB pathway. Shock. 2007;27(6):678-686.？ 

31. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends in biochemical sciences. 2005;30(1):43-52.？ 

32. Christian F, Smith EL, Carmody RJ. The regulation of NF-κB subunits by phosphorylation. Cells. 2016;5(1):12.？ 

33. Yasuda T. Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-κB via ICAM-1. Inflammation Research. 2007;56:246-253.？ 

34. Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D. HaCaT cells as a reliable in vitro differentiation model to dissect the inflammatory/repair response of human keratinocytes. Mediators of inflammation. 2017;2017.？ 

    상세보기

35. Wilson VG. Growth and differentiation of HaCaT keratinocytes. Epidermal Cells: Methods and Protocols. 2014:33-41.？ 

36. Cai L, Qin X, Xu Z, Song Y, Jiang H, Wu Y, Ruan H, Chen J. Comparison of cytotoxicity evaluation of anticancer drugs between real-time cell analysis and CCK-8 method. ACS omega. 2019;4(7):12036-12042.？ 

    상세보기

37. Kim H, Han TH, Lee SG. Anti-inflammatory activity of a water extract of Acorus calamus L. leaves on keratinocyte HaCaT cells. Journal of ethnopharmacology. 2009;122(1):149-156.？ 

    상세보기

38. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkB kinase complex (IKK) contains two kinase subunits, IKKa and IKKb, necessary for IkB phosphorylation and NF-kB activation. Cell. 1997;91(2):243-252.？ 

39. Magnani M, Crinelli R, Bianchi M, Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Current drug targets. 2000;1(4):387-399.？ 

    상세보기

40. Gilmore TD. The Rel/NF-κB signal transduction pathway: introduction. Oncogene. 1999;18(49):6842-6844. 

저자의 다른 논문 :

이용흠 (48)